You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 6, June 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human T-Cell Lymphotropic Virus Type I and Neurologic Disease in Panama, 1985 and 1986

Fernando Gracia, MD; William C. Reeves, MD, MSPH; Paul H. Levine, MD; Marina Cuevas, MT; Luis Castillo, MD; Rubén Chavarría, MD; Victor Grimaldo, MD; Ernesto Triana, MD; Juan Ramón Arosemena, MD; William A. Blattner, MD

Arch Neurol. 1990;47(6):634-639.


Abstract

• Human T-cell lymphotropic virus type I (HTLV-I) causes adult T-cell leukemia and has recently been associated with HTLV-associated myelopathy/tropical spastic paraparesis. The HTLV-I is endemic throughout the Caribbean basin and parts of South America, and HTLV-associated myelopathy/tropical spastic paraparesis also seems to be common in this area. This 2-year study, 1985 and 1986, was designed to evaluate the occurrence of HTLV-I infection in all newly diagnosed cases of selected neurologic diseases in Panama City, Panama. Six (8%) of 71 patients had antibody to HTLV-I detected by immunofluorescence, enzyme-linked immunosorbent assay, radioimmunoassay, and Western blot assays; 5 patients' conditions were diagnosed as spastic paraparesis, and all 5 were seropositive and also had HTLV-I antibody in cerebrospinal fluid. The remaining seropositive patient had multiple sclerosis, and no antibody was detected in her cerebrospinal fluid. Clinical and electrophysiologic studies indicated that HTLV-I-associated spastic paraparesis is a multifocal, primarily demyelinating disease that principally involves the spinal cord.



Author Affiliations

From the Neurology Service, Santo Tomas Hospital (Dr Gracia), the Division of Epidemiology, Gorgas Memorial Laboratory (Drs Reeves, Chavarría, Grimaldo, and Arosemena and Ms Cuevas), and the Neurology Service, Complejo Hospitalario Metropolitano-CSS (Drs Castillo and Triana), Panama City, Panama; and the Environmental Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (Drs Levine and Blattner). Dr Reeves is now with the Centers for Disease Control, Atlanta, Ga.


Footnotes

Accepted for publication September 29, 1989.

Reprint requests to the Viral Exanthems and Herpesvirus Branch G-18, Division of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta, GA 30333 (Dr Reeves).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I)
Gessain and Gout
ANN INTERN MED 1992;117:933-946.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.